Sort
21,281 grants matching “influenza”
Genetic & Structural Basis for Virus Neutralization: Studies on Influenza H7 Virus
$2,100,000Gay Nell H Krauss · Vanderbilt University · N01 · FY2016 · AI
The Infectious Diseases Clinical Research Program (IDCRP)
$2,098,800National Institute Of Allergy And Infectious Diseases · Y01 · FY2025 · AI
Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site
$2,098,592Karen L. Kotloff · University Of Maryland Baltimore · UM1 · FY2022 · AI
Advanced Development of Vaccines for Infectious Diseases
$2,098,124Ly Phan · Versatope Therapeutics, Inc. · N01 · FY2019 · AI
Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site
$2,095,587Karen L. Kotloff · University Of Maryland Baltimore · UM1 · FY2021 · AI
Integrative analysis and modeling of human immune responses and pathologies
$2,095,068John Tsang · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Modeling Early Immunity to Human Influenza Infection
$2,093,547Stuart C. Sealfon · Icahn School Of Medicine At Mount Sinai · U19 · FY2018 · AI
Pandemic influenza DNA vaccine Development
$2,090,882Lawrence R Smith · Vical, Inc. · U01 · FY2009 · AI
Integrating innate and adaptive pathways in vaccine responses
$2,088,086Jeffrey Victor Ravetch · Rockefeller University · U19 · FY2019 · AI
Integrating innate and adaptive pathways in vaccine responses
$2,087,906Jeffrey Victor Ravetch · Rockefeller University · U19 · FY2020 · AI
Integrating innate and adaptive pathways in vaccine responses
$2,087,668Jeffrey Victor Ravetch · Rockefeller University · U19 · FY2021 · AI
Integrating innate and adaptive pathways in vaccine responses
$2,087,498Jeffrey Victor Ravetch · Rockefeller University · U19 · FY2022 · AI
Integrating innate and adaptive pathways in vaccine responses
$2,087,423Jeffrey Victor Ravetch · Rockefeller University · U19 · FY2023 · AI
IP21-002, Enhanced Surveillance to Assess Vaccine Preventable Enteric and Respiratory Virus Illnesses
$2,082,196Janet A Englund · Seattle Children'S Hospital · U01 · FY2025 · IP
Modeling Immunity for Biodefense
$2,082,085Hulin Wu · University Of Rochester · N01 · FY2010 · AI
(HVTN) HIV VACCINE TRIAL UNITS
$2,081,637Johns Hopkins University · U01 · FY2003 · AI
Live attenuated vaccines for epidemic and pandemic flu
$2,081,495Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · U01 · FY2006 · AI
Emerging respiratory viruses - pathogenesis and countermeasures
$2,081,320Emmie De Wit · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Research Activities
$2,080,769Walter Orenstein · Emory University · N01 · FY2021 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE: UNIVERSAL INFLUENZA RESEARCH ACTIVITIES
$2,079,465S. Mark Tompkins · University Of Georgia · N01 · FY2023 · AI
Ancillary Study 1
$2,076,535Joseph Zabner · University Of Iowa · U01 · FY2011 · HL
Drivers of influenza A virus transmission in humans
$2,074,701Anice C Lowen · Emory University · P01 · FY2025 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS): UNIVERSAL INFLUENZA RESEARCH EFFORTS
$2,070,362Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · N01 · FY2019 · AI
Therapeutic Fully Human Monoclonal Antibodies against Vaccina Virus and Smallpox
$2,068,496Shane P Crotty · La Jolla Institute For Immunology · U01 · FY2009 · AI
Emerging Infections Program
$2,067,971Timothy F. Jones · Tennessee State Department Of Health · U01 · FY2010 · CI